Metformin is a safe and effective oral medication for people with type 2 diabetes. Here's how it can help regulate ...
Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy. (HealthDay News) — For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk ...
MedPage Today on MSN
Cardiovascular Risks Resurface Old Concerns About Sulfonylureas for T2D
Sulfonylureas were flagged for excess cardiovascular risk when used for additional glucose lowering in type 2 diabetes (T2D) in an observational comparative effectiveness study. As second-line ...
Metformin is an unassuming hero of modern medicine. For more than 60 years, this humble pill has been a mainstay of diabetes care, helping millions of people manage their blood sugar. It lowers blood ...
HealthDay News — For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk treated with metformin, the risk for major adverse cardiovascular events is highest for glipizide as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results